S. Niru Nirthanan is a highly accomplished academic and medical professional with extensive experience in pharmacology and medical education. Currently serving as the Dean of Medicine and Professor of Pharmacology at Griffith University, Nirthanan has held various leadership roles, including Program Director for the Doctor of Medicine and Medical and Biomedical Science Programs. Nirthanan is also the Editor-in-Chief of Toxin Reviews and a Fellow of both the British Pharmacological Society and the Academy of Medical Educators. With a strong background in neuroscience, including postdoctoral training at Harvard Medical School, Nirthanan has contributed significantly to pharmacology education and research, holding key positions within multiple prestigious organizations, including ASPET. Nirthanan holds degrees in Medicine and Surgery, a PhD in Pharmacology, and has engaged in mentoring initiatives for STEM professionals.
This person is not in any offices
American Society for Pharmacology and Experimental Therapeutics - ASPET
The American Society for Pharmacology and Experimental Therapeutics (ASPET) is a 4,000 member scientific society whose members conduct basic and clinical pharmacological research in academia, industry and the government. Our members research efforts help develop new medicines and therapeutic agents to fight existing and emerging diseases. ASPET supports 10 Divisions, each of which is governed by an Executive Committee. •Division for Behavioral Pharmacology •Division for Cancer Pharmacology •Division for Cardiovascular Pharmacology •Division for Drug Discovery and Development •Division for Drug Metabolism and Disposition •Division for Molecular Pharmacology •Division for Neuropharmacology •Division for Pharmacology Education •Division for Toxicology •Division for Translational and Clinical Pharmacology ASPET is located in Rockville, Maryland. ASPET is a founding member of the Federation of American Societies for Experimental Biology.